Reuters logo
BRIEF-Pluristem Therapeutics says phase III CLI trial cleared to commence enrollment in U.S. and EU
February 13, 2017 / 12:20 PM / 8 months ago

BRIEF-Pluristem Therapeutics says phase III CLI trial cleared to commence enrollment in U.S. and EU

Feb 13 (Reuters) - Pluristem Therapeutics Inc

* Pluristem reports second quarter fiscal 2017 highlights & provides calendar 2017 outlook

* Company expects to begin enrolling patients in this study in first half of 2017

* Pluristem therapeutics - study initiation of pivotal phase III trial in CLI received clearance from regulatory authorities in U.S., U.K. And Germany

* Pivotal phase III CLI trial cleared to commence enrollment in U.S. and EU in H1 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below